Aldosterone: Cardiovascular assault

被引:59
作者
Struthers, AD [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Dundee DD1 9SY, Scotland
关键词
D O I
10.1067/mhj.2002.129969
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Blocking the renin-angiotensin-aldosterone system with angiotensin-converting enzyme inhibitors has improved cardiovascular morbidity and mortality rates. However, because of aldosterone "escape," the effectiveness of this blockade decreases over time. Methods Various in vitro and in vivo studies were evaluated to determine the mechanisms by which aldosterone contributes to morbidity and mortality. Results Aldosterone has several deleterious properties. It causes a vasculopathy with both endothelial dysfunction and a reduction in fibrinolysis, leading to heart, brain, and kidney damage. Aldosterone causes myocardial hypertrophy and fibrosis, autonomic imbalance, and electrolyte abnormalities, contributing to myocardial dysfunction, arrhythmias, and sudden cardiac death. Studies have shown that all of these deleterious effects can, at least in part, be reversed by aldosterone receptor blockade. This may explain why adding an aldosterone blocker to standard heart failure therapy, including angiotensin-converting enzyme inhibitors, reduces morbidity and mortality rates by an additional 30% compared with standard therapy alone. Conclusions Eplerenone is a selective aldosterone blocker whose role in reducing morbidity and mortality rates in patients with cardiovascular disease is being investigated.
引用
收藏
页码:S2 / S7
页数:6
相关论文
共 38 条
  • [1] Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men
    Ascherio, A
    Rimm, EB
    Hernán, MA
    Giovannucci, EL
    Kawachi, I
    Stampfer, MJ
    Willett, WC
    [J]. CIRCULATION, 1998, 98 (12) : 1198 - 1204
  • [2] EFFECTS OF ADDING SPIRONOLACTONE TO AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE
    BARR, CS
    LANG, CC
    HANSON, J
    ARNOTT, M
    KENNEDY, N
    STRUTHERS, AD
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (17) : 1259 - 1265
  • [3] INFLUENCE OF THE ARTERIAL BLOOD-PRESSURE AND NONHEMODYNAMIC FACTORS ON LEFT-VENTRICULAR HYPERTROPHY IN MODERATE ESSENTIAL-HYPERTENSION
    BAUWENS, FR
    DUPREZ, DA
    DEBUYZERE, ML
    DEBACKER, TL
    KAUFMAN, JM
    VANHOECKE, J
    VERMEULEN, A
    CLEMENT, DL
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (09) : 925 - 929
  • [4] Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension
    Blacher, J
    Amah, G
    Girerd, X
    Kheder, A
    Ben Mais, H
    London, GM
    Safar, ME
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (12) : 1326 - 1334
  • [5] ANTI-ALDOSTERONE TREATMENT AND THE PREVENTION OF MYOCARDIAL FIBROSIS IN PRIMARY AND SECONDARY HYPERALDOSTERONISM
    BRILLA, CG
    MATSUBARA, LS
    WEBER, KT
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1993, 25 (05) : 563 - 575
  • [6] BRILLA CGT, 1993, AM J CARDIOL, V71
  • [7] Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
    Brown, NJ
    Nakamura, S
    Ma, LJ
    Nakamura, I
    Donnert, E
    Freeman, M
    Vaughan, DE
    Fogo, AB
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (03) : 1219 - 1227
  • [8] Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1
    Brown, NJ
    Agirbasli, MA
    Williams, GH
    Litchfield, WR
    Vaughan, DE
    [J]. HYPERTENSION, 1998, 32 (06) : 965 - 971
  • [9] Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production
    Brown, NJ
    Kim, KS
    Chen, YQ
    Blevins, LS
    Nadeau, JH
    Meranze, SG
    Vaughan, DE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) : 336 - 344
  • [10] A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
    Cohn, JN
    Tognoni, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) : 1667 - 1675